Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $131.91 million. The enterprise value is $90.78 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 68.70 million shares outstanding. The number of shares has increased by 53.38% in one year.
| Current Share Class | 68.70M |
| Shares Outstanding | 68.70M |
| Shares Change (YoY) | +53.38% |
| Shares Change (QoQ) | +34.35% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 30.16% |
| Float | 68.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 721.56 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 497.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79
| Current Ratio | 0.79 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -328.45% and return on invested capital (ROIC) is -127.02%.
| Return on Equity (ROE) | -328.45% |
| Return on Assets (ROA) | -63.56% |
| Return on Invested Capital (ROIC) | -127.02% |
| Return on Capital Employed (ROCE) | 20,471.67% |
| Revenue Per Employee | $1,361 |
| Profits Per Employee | -$806,660 |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.56% in the last 52 weeks. The beta is 1.54, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -55.56% |
| 50-Day Moving Average | 2.27 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 43.50 |
| Average Volume (20 Days) | 1,358,848 |
Short Selling Information
The latest short interest is 8.26 million, so 12.02% of the outstanding shares have been sold short.
| Short Interest | 8.26M |
| Short Previous Month | 8.21M |
| Short % of Shares Out | 12.02% |
| Short % of Float | 12.07% |
| Short Ratio (days to cover) | 6.41 |
Income Statement
In the last 12 months, INO had revenue of $182,337 and -$108.09 million in losses. Loss per share was -$2.78.
| Revenue | 182,337 |
| Gross Profit | -56.65M |
| Operating Income | -89.72M |
| Pretax Income | -108.09M |
| Net Income | -108.09M |
| EBITDA | -88.22M |
| EBIT | -89.72M |
| Loss Per Share | -$2.78 |
Full Income StatementBalance Sheet
The company has $50.80 million in cash and $10.02 million in debt, giving a net cash position of $40.78 million or $0.59 per share.
| Cash & Cash Equivalents | 50.80M |
| Total Debt | 10.02M |
| Net Cash | 40.78M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | -7.72M |
| Book Value Per Share | -0.14 |
| Working Capital | -14.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$88.92 million and capital expenditures -$158,254, giving a free cash flow of -$89.08 million.
| Operating Cash Flow | -88.92M |
| Capital Expenditures | -158,254 |
| Free Cash Flow | -89.08M |
| FCF Per Share | -$1.30 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -49,202.88% |
| Pretax Margin | -59,281.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.38% |
| Shareholder Yield | -53.38% |
| Earnings Yield | -82.16% |
| FCF Yield | -67.71% |
Dividend DetailsAnalyst Forecast
The average price target for INO is $9.00, which is 368.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.00 |
| Price Target Difference | 368.75% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 230.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
INO has an Altman Z-Score of -40.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.51 |
| Piotroski F-Score | 3 |
